LifeVantage (NASDAQ:LFVN – Get Free Report) announced its quarterly earnings data on Tuesday. The company reported $0.15 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.15, Zacks reports. LifeVantage had a net margin of 1.47% and a return on equity of 27.85%. The company had revenue of $47.21 million during the quarter. LifeVantage updated its FY 2025 guidance to 0.700-0.800 EPS.
LifeVantage Price Performance
Shares of NASDAQ:LFVN traded down $0.16 during trading hours on Thursday, hitting $12.77. The company’s stock had a trading volume of 11,045 shares, compared to its average volume of 60,067. LifeVantage has a 52 week low of $4.20 and a 52 week high of $14.71. The company has a market capitalization of $162.19 million, a price-to-earnings ratio of 46.18 and a beta of 0.84. The firm’s fifty day moving average price is $10.86 and its 200 day moving average price is $8.35.
LifeVantage Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Monday, December 2nd will be issued a $0.04 dividend. The ex-dividend date is Monday, December 2nd. This represents a $0.16 annualized dividend and a dividend yield of 1.25%. LifeVantage’s dividend payout ratio is currently 57.14%.
LifeVantage Company Profile
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.
Further Reading
- Five stocks we like better than LifeVantage
- What is a Low P/E Ratio and What Does it Tell Investors?
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- What is the NASDAQ Stock Exchange?
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Caterpillar Stock: Market Points to a Buying Opportunity
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.
